The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers
Clinical trial NCT05954611 · COMPLETED
Trial details
- NCT number
- NCT05954611
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-16
- Primary completion
- 2024-01-02
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.